151 related articles for article (PubMed ID: 9864429)
1. Absence of epidermal growth factor receptor expression in squamous cell carcinoma of the uterine cervix is an indicator of limited tumor disease.
Biesterfeld S; Schuh S; Muys L; Rath W; Mittermayer C; Schröder W
Oncol Rep; 1999; 6(1):205-9. PubMed ID: 9864429
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical demonstration of elevated expression of epidermal growth factor receptor in the neoplastic changes of cervical squamous epithelium.
Maruo T; Yamasaki M; Ladines-Llave CA; Mochizuki M
Cancer; 1992 Mar; 69(5):1182-7. PubMed ID: 1739918
[TBL] [Abstract][Full Text] [Related]
3. [Immunohistochemical studies on epidermal growth factor receptor in oncogenesis of uterine cervical cancer].
Ueda M
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1401-8. PubMed ID: 2685140
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of epidermal growth factor receptor expression in cervical carcinoma.
Hale RJ; Buckley CH; Gullick WJ; Fox H; Williams J; Wilcox FL
J Clin Pathol; 1993 Feb; 46(2):149-53. PubMed ID: 8459036
[TBL] [Abstract][Full Text] [Related]
5. Clinical implications of the epidermal growth factor receptor in the squamous cell carcinoma of the uterine cervix.
Pfeiffer D; Stellwag B; Pfeiffer A; Borlinghaus P; Meier W; Scheidel P
Gynecol Oncol; 1989 May; 33(2):146-50. PubMed ID: 2784777
[TBL] [Abstract][Full Text] [Related]
6. Grading system of lymphatic invasion according to D2-40 immunostaining is useful for the prediction of nodal metastasis in squamous cell carcinoma of the uterine cervix.
Urabe A; Matsumoto T; Kimura M; Sonoue H; Kinoshita K
Histopathology; 2006 Nov; 49(5):493-7. PubMed ID: 17064295
[TBL] [Abstract][Full Text] [Related]
7. [Immunohistochemical studies on epidermal growth factor receptor and the myc oncogene product in squamous cell carcinoma of the uterine cervix].
Yamasaki M; Maruo T; Akahori T; Mochizuki M
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Jan; 40(1):51-8. PubMed ID: 3280708
[TBL] [Abstract][Full Text] [Related]
8. Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival.
Rubin Grandis J; Melhem MF; Gooding WE; Day R; Holst VA; Wagener MM; Drenning SD; Tweardy DJ
J Natl Cancer Inst; 1998 Jun; 90(11):824-32. PubMed ID: 9625170
[TBL] [Abstract][Full Text] [Related]
9. [Characterization of the EGF receptor status in penile cancer : retrospective analysis of the course of the disease in 45 patients].
Börgermann C; Schmitz KJ; Sommer S; Rübben H; Krege S
Urologe A; 2009 Dec; 48(12):1483-9. PubMed ID: 19760386
[TBL] [Abstract][Full Text] [Related]
10. [EGF receptor and EGF-like activity as prognostic factors in cervix cancer].
Stellwag B; Scheidel P; Pfeiffer D; Hepp H
Geburtshilfe Frauenheilkd; 1993 Mar; 53(3):177-81. PubMed ID: 8467984
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis of c-erbB-2 oncogene product and epidermal growth factor receptor expression in human urinary bladder carcinomas.
Asamoto M; Hasegawa R; Masuko T; Hashimoto Y; Ueda K; Ohtaguro K; Sasaki S; Washida H; Fukushima S
Acta Pathol Jpn; 1990 May; 40(5):322-6. PubMed ID: 2203226
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the prognostic significance of nm23/NDP kinase protein expression in cervical carcinoma: an immunohistochemical study.
Kristensen GB; Holm R; Abeler VM; Tropé CG
Gynecol Oncol; 1996 Jun; 61(3):378-83. PubMed ID: 8641619
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of lymph node status and lymph node morphology in cervix cancer operated by the Wertheim-Meigs-Okabayashi method].
Geppert M; Smyczek-Gargya B; Dekorsy A; König PA
Zentralbl Gynakol; 1992; 114(3):122-6. PubMed ID: 1595306
[TBL] [Abstract][Full Text] [Related]
14. [Immunohistochemical studies on epidermal growth factor receptor in experimental squamous cell carcinoma of the uterine cervix of mice].
Ueda M; Yanagawa Y; Okamoto Y; Yamada T; Misaki O; Seiki Y; Tsurunaga T; Iwai E; Ueki M; Sugimoto O
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Oct; 40(10):1506-11. PubMed ID: 3225481
[TBL] [Abstract][Full Text] [Related]
15. Oncogene proteins and proliferation antigens in thymomas: increased expression of epidermal growth factor receptor and Ki67 antigen.
Gilhus NE; Jones M; Turley H; Gatter KC; Nagvekar N; Newsom-Davis J; Willcox N
J Clin Pathol; 1995 May; 48(5):447-55. PubMed ID: 7629292
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of immunohistochemically detected p53 protein expression in stage IIIB squamous cell carcinoma of the uterine cervix treated with radiation therapy alone.
Ebara T; Mitsuhashi N; Saito Y; Sakurai H; Hasegawa M; Takahashi M; Takahashi T; Hayakawa K; Niibe H
Gynecol Oncol; 1996 Nov; 63(2):216-8. PubMed ID: 8910630
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the prognostic significance of cathepsin D, epidermal growth factor receptor, and c-erbB-2 in early cervical squamous cell carcinoma. An immunohistochemical study.
Kristensen GB; Holm R; Abeler VM; Tropé CG
Cancer; 1996 Aug; 78(3):433-40. PubMed ID: 8697388
[TBL] [Abstract][Full Text] [Related]
18. [Study of the expression of the epidermal growth factor-receptor in the laryngeal squamous cell carcinoma and the correlation with clinical pathology characteristics].
Fu Z; Wang J
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1997 Apr; 11(4):147-9. PubMed ID: 9644164
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of p53 expression in stage IB1 cervical carcinoma.
Chen HY; Hsu CT; Lin WC; Tsai HD; Chang WC
Gynecol Obstet Invest; 2000; 49(4):266-71. PubMed ID: 10828711
[TBL] [Abstract][Full Text] [Related]
20. c-erbB-2 Oncoprotein expression is associated with poor prognosis in squamous cell carcinoma of the cervix.
Oka K; Nakano T; Arai T
Cancer; 1994 Feb; 73(3):664-71. PubMed ID: 7905364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
